Latest in News & Research
Dermatologist Visits Shorter for Asian Psoriasis Patients
Asian patients have visits of shorter mean duration compared with White patients, non-Asian patients as a single group
By Physician’s Briefing Staff | | August 08, 2022
Two Years of Tralokinumab Safe, Efficacious for Atopic Dermatitis
75 percent improvement in Eczema Area and Severity Index was 82.5 percent with two years of tralokinumab
By Dermsquared Editorial Team | | August 03, 2022
Did COVID-19 Diagnostic Delay Affect Melanoma, cSCC Characteristics?
No significant differences seen in mean primary melanoma Breslow thickness for prepandemic era, subsequent periods
By Dermsquared Editorial Team | | August 03, 2022
Banana Boat Sunscreen Recalled Due to Benzene
Company says it has not received any reports of adverse events
By Cara Murez (HealthDay News) | | August 01, 2022
Characteristics of Photoaggravated Atopic Dermatitis Described
Response rates for deucravacitinib significantly higher versus placebo or apremilast for PASI 75, sPGA 0/1
By Dermsquared Editorial Team | | July 27, 2022
Is Deucravacitinib Effective, Well Tolerated for Plaque Psoriasis?
Response rates for deucravacitinib significantly higher versus placebo or apremilast for PASI 75, sPGA 0/1
By Dermsquared Editorial Team | | July 27, 2022
AI and Dermatologists Similarly Judge Melanoma Thickness
Readers most accurately discriminated between thin (≤1.0 mm) and thick melanomas (>1.0 mm)
By Physician’s Briefing Staff | | July 26, 2022
Manifestations of Monkeypox Described in Case Series
95 percent of 528 cases presented with rash; 73 and 41 percent had anogenital and mucosal lesions, respectively
By Physician's Briefing Staff | | July 25, 2022
T-Cell-Rich Lymphoid Infiltrates ID'd After Pfizer COVID-19 Shot
Three types of infiltrates revealed on histologic examination including cutaneous T-cell lymphoid hyperplasia
By Dermsquared Editorial Team | | July 20, 2022
Does Margin Status Impact Recurrence in Scalp cSCC?
No association seen with risk for local recurrence, but five-year disease-specific mortality lower for patients with clear margins versus close/involved margins
By Dermsquared Editorial Team | | July 20, 2022
FDA Approves First Topical Treatment for Vitiligo
Opzelura can be used twice daily in patients ages 12 years and older
By Physician’s Briefing Staff | | July 20, 2022
Smoking Is Causally Associated With Psoriasis Risk
Causal effect found of smoking initiation, cigarettes per day, lifetime smoking on psoriasis; no causal link seen for alcohol consumption
By Physician’s Briefing Staff | | July 20, 2022
Urgent Health Care Use Up for Adults With Concomitant Eczema, Asthma
Those with concomitant atopic dermatitis, asthma had increased risk for hospitalizations and fewer visits in outpatient clinics
By Physician’s Briefing Staff | | July 19, 2022
Berdazimer Gel Efficacious, Safe for Molluscum Contagiosum
Odds of complete clearance of MC lesions increased for patients receiving berdazimer gel 10.3 percent versus vehicle for 12 weeks
By Dermsquared Editorial Team | | July 13, 2022
Do Melanoma Surgical Delays Impact Mortality Outcomes?
Adjusted survival curves from the multivariable model for effectiveness showed higher drug survival for guselkumab
By Dermsquared Editorial Team | | July 13, 2022
Tapinarof Effective for Longer-Term Treatment of Plaque Psoriasis
Complete disease clearance observed in 41 percent of patients with tapinarof cream 1 percent used once daily
By Physician’s Briefing Staff | | July 13, 2022
Many Younger Adults Lack Sun Protection Knowledge
Survey shows lack of knowledge may lead to behaviors that contribute to sun damage, skin cancer
By Physician's Briefing Staff | | July 12, 2022
Study Compares Biologics for Long-Term Treatment of Psoriasis
Adjusted survival curves from the multivariable model for effectiveness showed higher drug survival for guselkumab
By Dermsquared Editorial Team | | July 06, 2022
Skindex-Mini Can Play Role in ID'ing Pediatric Eczema Severity
Based on validated IGA, EASI, POEM, and CDLQI, the Skindex-Mini Total score could distinguish atopic dermatitis severity
By Dermsquared Editorial Team | | July 06, 2022
Many Gen Z Americans Have Sun Safety All Wrong
By Physician's Briefing Staff | | July 06, 2022
Rise in Cost of Biologics for Psoriasis Outpacing Medical Inflation
Apart from secukinumab, the mean cost of biologics increased by >100 percent than inflation alone would explain
By Physician’s Briefing Staff | | July 05, 2022
Twelve-Week Treatment Regimen Reduces Facial Redness
Skin seemed less inflamed, improvement seen in overall skin appearance, and skin looked and felt healthier
By Physician’s Briefing Staff | | July 01, 2022
What Factors Are Associated With the Burden of Atopic Dermatitis?
Atopic dermatitis severity and time spent managing symptoms have the strongest associations with disease burden
By Dermsquared Editorial Team | | June 29, 2022
24 of 1244
Headline from the Week of April 13 - 19, 2026
News Alert: Deucravacitinib Approved for Psoriatic Arthritis
By Dermsquared Editorial Team | | April 17, 2026
What It Means to Treat Something That Doesn’t Behave Consistently
| April 15, 2026